These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The myelin oligodendrocyte glycoprotein (MOG): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis. Stefferl A; Brehm U; Linington C J Neural Transm Suppl; 2000; (58):123-33. PubMed ID: 11128602 [TBL] [Abstract][Full Text] [Related]
3. Myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the common marmoset reflects the immunopathology of pattern II multiple sclerosis lesions. Merkler D; Schmelting B; Czéh B; Fuchs E; Stadelmann C; Brück W Mult Scler; 2006 Aug; 12(4):369-74. PubMed ID: 16900750 [TBL] [Abstract][Full Text] [Related]
4. Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis. Lolli F; Rovero P; Chelli M; Papini AM Neurology; 2005 Sep; 65(5):781-2; author reply 781-2. PubMed ID: 16157927 [No Abstract] [Full Text] [Related]
5. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390 [TBL] [Abstract][Full Text] [Related]